
APH · NYSE
Expected to report Jan 27, 2027 — estimated from last year’s reporting date.
Consensus is $0.82 EPS for Dec 2026 across 2 estimates, ranging $0.82 to $0.82.
Amphenol delivered a record third quarter that exceeded the high end of management’s guidance, with $10.23 billion of sales and $0.80 of adjusted diluted EPS. Adjusted EPS topped the supplied $0.73 consensus by 9.6%; GAAP diluted EPS was $0.79. Year over year, sales rose 65% and adjusted EPS 74%, while sales increased about 17% sequentially from Q2’s $8.76 billion. The company’s growth was both acquisition-assisted and organic: acquisitions contributed 28 percentage points to sales growth, while organic growth was 37%.
The defining driver was IT Datacom, now 48% of sales, where organic growth reached 77% and AI applications accounted for about three-quarters of the business. Orders reached a record $12.2 billion, a 1.19 book-to-bill, and adjusted operating margin expanded to 29.7% from 27.5% a year ago. Growth was broad across many markets, but not uniform: Communications Networks organic sales declined 28%, and management expects further softness there. The outlook remains strong: fourth-quarter sales of $10.3–$10.5 billion and adjusted EPS of $0.81–$0.83; full-year sales of $36.9–$37.1 billion and adjusted EPS of $2.82–$2.84. The company also raised its dividend and authorized a new $4 billion buyback program.